publication venue for
- Intedanib, a triple kinase inhibitor of VEGFR, FGFR and PDGFR for the treatment of cancer and idiopathic pulmonary fibrosis.. 13:332-345. 2010
- Drug evaluation: AP-23573--an mTOR inhibitor for the treatment of cancer.. 9:636-644. 2006
- Drug evaluation: E-5564.. 7:582-590. 2004
- Tifacogin (Chiron Corp/Pharmacia Corp).. 5:91-97. 2002
- Ilodecakin. Schering-Plough Corp.. 2:1045-1058. 1999